Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Beraprost sodium

EU orphan designation number: EU/3/01/053
Active ingredient: Beraprost sodium
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Aventis Pharma S.A.
20 avenue Raymond Aron, F-92165 Antony CEDEX, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/09/2001 Orphan designation EMEA/OD/015/01 (2001)2713 of 18/09/2001
19/02/2004 Removal of orphan designation from Community Register